1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncology Precision Medicine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Applied Sciences
1.2.3 Precision Diagnostics
1.2.4 Digital Health and Information Technology
1.2.5 Precision Therapeutics
1.3 Market by Application
1.3.1 Global Oncology Precision Medicine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Breast Cancer
1.3.3 Lung Cancer
1.3.4 Colorectal Cancer
1.3.5 Prostate Cancer
1.3.6 Cervical Cancer
1.3.7 Other Cancer
1.4 Study Objectives
1.5 Years Considered 2 Global Growth Trends
2.1 Global Oncology Precision Medicine Market Perspective (2017-2028)
2.2 Oncology Precision Medicine Growth Trends by Region
2.2.1 Oncology Precision Medicine Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Oncology Precision Medicine Historic Market Size by Region (2017-2022)
2.2.3 Oncology Precision Medicine Forecasted Market Size by Region (2023-2028)
2.3 Oncology Precision Medicine Market Dynamics
2.3.1 Oncology Precision Medicine Industry Trends
2.3.2 Oncology Precision Medicine Market Drivers
2.3.3 Oncology Precision Medicine Market Challenges
2.3.4 Oncology Precision Medicine Market Restraints 3 Competition Landscape by Key Players
3.1 Global Top Oncology Precision Medicine Players by Revenue
3.1.1 Global Top Oncology Precision Medicine Players by Revenue (2017-2022)
3.1.2 Global Oncology Precision Medicine Revenue Market Share by Players (2017-2022)
3.2 Global Oncology Precision Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oncology Precision Medicine Revenue
3.4 Global Oncology Precision Medicine Market Concentration Ratio
3.4.1 Global Oncology Precision Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncology Precision Medicine Revenue in 2021
3.5 Oncology Precision Medicine Key Players Head office and Area Served
3.6 Key Players Oncology Precision Medicine Product Solution and Service
3.7 Date of Enter into Oncology Precision Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans 4 Oncology Precision Medicine Breakdown Data by Type
4.1 Global Oncology Precision Medicine Historic Market Size by Type (2017-2022)
4.2 Global Oncology Precision Medicine Forecasted Market Size by Type (2023-2028) 5 Oncology Precision Medicine Breakdown Data by Application
5.1 Global Oncology Precision Medicine Historic Market Size by Application (2017-2022)
5.2 Global Oncology Precision Medicine Forecasted Market Size by Application (2023-2028) 6 North America
6.1 North America Oncology Precision Medicine Market Size (2017-2028)
6.2 North America Oncology Precision Medicine Market Size by Type
6.2.1 North America Oncology Precision Medicine Market Size by Type (2017-2022)
6.2.2 North America Oncology Precision Medicine Market Size by Type (2023-2028)
6.2.3 North America Oncology Precision Medicine Market Share by Type (2017-2028)
6.3 North America Oncology Precision Medicine Market Size by Application
6.3.1 North America Oncology Precision Medicine Market Size by Application (2017-2022)
6.3.2 North America Oncology Precision Medicine Market Size by Application (2023-2028)
6.3.3 North America Oncology Precision Medicine Market Share by Application (2017-2028)
6.4 North America Oncology Precision Medicine Market Size by Country
6.4.1 North America Oncology Precision Medicine Market Size by Country (2017-2022)
6.4.2 North America Oncology Precision Medicine Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada 7 Europe
7.1 Europe Oncology Precision Medicine Market Size (2017-2028)
7.2 Europe Oncology Precision Medicine Market Size by Type
7.2.1 Europe Oncology Precision Medicine Market Size by Type (2017-2022)
7.2.2 Europe Oncology Precision Medicine Market Size by Type (2023-2028)
7.2.3 Europe Oncology Precision Medicine Market Share by Type (2017-2028)
7.3 Europe Oncology Precision Medicine Market Size by Application
7.3.1 Europe Oncology Precision Medicine Market Size by Application (2017-2022)
7.3.2 Europe Oncology Precision Medicine Market Size by Application (2023-2028)
7.3.3 Europe Oncology Precision Medicine Market Share by Application (2017-2028)
7.4 Europe Oncology Precision Medicine Market Size by Country
7.4.1 Europe Oncology Precision Medicine Market Size by Country (2017-2022)
7.4.2 Europe Oncology Precision Medicine Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries 8 Asia-Pacific
8.1 Asia-Pacific Oncology Precision Medicine Market Size (2017-2028)
8.2 Asia-Pacific Oncology Precision Medicine Market Size by Type
8.2.1 Asia-Pacific Oncology Precision Medicine Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Oncology Precision Medicine Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Oncology Precision Medicine Market Share by Type (2017-2028)
8.3 Asia-Pacific Oncology Precision Medicine Market Size by Application
8.3.1 Asia-Pacific Oncology Precision Medicine Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Oncology Precision Medicine Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Oncology Precision Medicine Market Share by Application (2017-2028)
8.4 Asia-Pacific Oncology Precision Medicine Market Size by Region
8.4.1 Asia-Pacific Oncology Precision Medicine Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Oncology Precision Medicine Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia 9 Latin America
9.1 Latin America Oncology Precision Medicine Market Size (2017-2028)
9.2 Latin America Oncology Precision Medicine Market Size by Type
9.2.1 Latin America Oncology Precision Medicine Market Size by Type (2017-2022)
9.2.2 Latin America Oncology Precision Medicine Market Size by Type (2023-2028)
9.2.3 Latin America Oncology Precision Medicine Market Share by Type (2017-2028)
9.3 Latin America Oncology Precision Medicine Market Size by Application
9.3.1 Latin America Oncology Precision Medicine Market Size by Application (2017-2022)
9.3.2 Latin America Oncology Precision Medicine Market Size by Application (2023-2028)
9.3.3 Latin America Oncology Precision Medicine Market Share by Application (2017-2028)
9.4 Latin America Oncology Precision Medicine Market Size by Country
9.4.1 Latin America Oncology Precision Medicine Market Size by Country (2017-2022)
9.4.2 Latin America Oncology Precision Medicine Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil 10 Middle East & Africa
10.1 Middle East & Africa Oncology Precision Medicine Market Size (2017-2028)
10.2 Middle East & Africa Oncology Precision Medicine Market Size by Type
10.2.1 Middle East & Africa Oncology Precision Medicine Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Oncology Precision Medicine Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Oncology Precision Medicine Market Share by Type (2017-2028)
10.3 Middle East & Africa Oncology Precision Medicine Market Size by Application
10.3.1 Middle East & Africa Oncology Precision Medicine Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Oncology Precision Medicine Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Oncology Precision Medicine Market Share by Application (2017-2028)
10.4 Middle East & Africa Oncology Precision Medicine Market Size by Country
10.4.1 Middle East & Africa Oncology Precision Medicine Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Oncology Precision Medicine Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE 11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Oncology Precision Medicine Introduction
11.1.4 Abbott Laboratories Revenue in Oncology Precision Medicine Business (2017-2022)
11.1.5 Abbott Laboratories Recent Developments
11.2 Agilent Technologies
11.2.1 Agilent Technologies Company Details
11.2.2 Agilent Technologies Business Overview
11.2.3 Agilent Technologies Oncology Precision Medicine Introduction
11.2.4 Agilent Technologies Revenue in Oncology Precision Medicine Business (2017-2022)
11.2.5 Agilent Technologies Recent Developments
11.3 Almac
11.3.1 Almac Company Details
11.3.2 Almac Business Overview
11.3.3 Almac Oncology Precision Medicine Introduction
11.3.4 Almac Revenue in Oncology Precision Medicine Business (2017-2022)
11.3.5 Almac Recent Developments
11.4 ANGLE plc
11.4.1 ANGLE plc Company Details
11.4.2 ANGLE plc Business Overview
11.4.3 ANGLE plc Oncology Precision Medicine Introduction
11.4.4 ANGLE plc Revenue in Oncology Precision Medicine Business (2017-2022)
11.4.5 ANGLE plc Recent Developments
11.5 Asuragen
11.5.1 Asuragen Company Details
11.5.2 Asuragen Business Overview
11.5.3 Asuragen Oncology Precision Medicine Introduction
11.5.4 Asuragen Revenue in Oncology Precision Medicine Business (2017-2022)
11.5.5 Asuragen Recent Developments
11.6 BGI Group
11.6.1 BGI Group Company Details
11.6.2 BGI Group Business Overview
11.6.3 BGI Group Oncology Precision Medicine Introduction
11.6.4 BGI Group Revenue in Oncology Precision Medicine Business (2017-2022)
11.6.5 BGI Group Recent Developments
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Company Details
11.7.2 Bio-Rad Laboratories Business Overview
11.7.3 Bio-Rad Laboratories Oncology Precision Medicine Introduction
11.7.4 Bio-Rad Laboratories Revenue in Oncology Precision Medicine Business (2017-2022)
11.7.5 Bio-Rad Laboratories Recent Developments
11.8 BioM?rieux
11.8.1 BioM?rieux Company Details
11.8.2 BioM?rieux Business Overview
11.8.3 BioM?rieux Oncology Precision Medicine Introduction
11.8.4 BioM?rieux Revenue in Oncology Precision Medicine Business (2017-2022)
11.8.5 BioM?rieux Recent Developments
11.9 Bristol Myers Squibb
11.9.1 Bristol Myers Squibb Company Details
11.9.2 Bristol Myers Squibb Business Overview
11.9.3 Bristol Myers Squibb Oncology Precision Medicine Introduction
11.9.4 Bristol Myers Squibb Revenue in Oncology Precision Medicine Business (2017-2022)
11.9.5 Bristol Myers Squibb Recent Developments
11.10 Roche Holding AG
11.10.1 Roche Holding AG Company Details
11.10.2 Roche Holding AG Business Overview
11.10.3 Roche Holding AG Oncology Precision Medicine Introduction
11.10.4 Roche Holding AG Revenue in Oncology Precision Medicine Business (2017-2022)
11.10.5 Roche Holding AG Recent Developments
11.11 Gilead Sciences
11.11.1 Gilead Sciences Company Details
11.11.2 Gilead Sciences Business Overview
11.11.3 Gilead Sciences Oncology Precision Medicine Introduction
11.11.4 Gilead Sciences Revenue in Oncology Precision Medicine Business (2017-2022)
11.11.5 Gilead Sciences Recent Developments
11.12 Illumina
11.12.1 Illumina Company Details
11.12.2 Illumina Business Overview
11.12.3 Illumina Oncology Precision Medicine Introduction
11.12.4 Illumina Revenue in Oncology Precision Medicine Business (2017-2022)
11.12.5 Illumina Recent Developments
11.13 Konica Minolta
11.13.1 Konica Minolta Company Details
11.13.2 Konica Minolta Business Overview
11.13.3 Konica Minolta Oncology Precision Medicine Introduction
11.13.4 Konica Minolta Revenue in Oncology Precision Medicine Business (2017-2022)
11.13.5 Konica Minolta Recent Developments
11.14 LabCorp
11.14.1 LabCorp Company Details
11.14.2 LabCorp Business Overview
11.14.3 LabCorp Oncology Precision Medicine Introduction
11.14.4 LabCorp Revenue in Oncology Precision Medicine Business (2017-2022)
11.14.5 LabCorp Recent Developments
11.15 MDxHealth
11.15.1 MDxHealth Company Details
11.15.2 MDxHealth Business Overview
11.15.3 MDxHealth Oncology Precision Medicine Introduction
11.15.4 MDxHealth Revenue in Oncology Precision Medicine Business (2017-2022)
11.15.5 MDxHealth Recent Developments
11.16 Myriad Genetics
11.16.1 Myriad Genetics Company Details
11.16.2 Myriad Genetics Business Overview
11.16.3 Myriad Genetics Oncology Precision Medicine Introduction
11.16.4 Myriad Genetics Revenue in Oncology Precision Medicine Business (2017-2022)
11.16.5 Myriad Genetics Recent Developments
11.17 Novartis
11.17.1 Novartis Company Details
11.17.2 Novartis Business Overview
11.17.3 Novartis Oncology Precision Medicine Introduction
11.17.4 Novartis Revenue in Oncology Precision Medicine Business (2017-2022)
11.17.5 Novartis Recent Developments
11.18 OPKO Health
11.18.1 OPKO Health Company Details
11.18.2 OPKO Health Business Overview
11.18.3 OPKO Health Oncology Precision Medicine Introduction
11.18.4 OPKO Health Revenue in Oncology Precision Medicine Business (2017-2022)
11.18.5 OPKO Health Recent Developments
11.19 Pacific Biosciences
11.19.1 Pacific Biosciences Company Details
11.19.2 Pacific Biosciences Business Overview
11.19.3 Pacific Biosciences Oncology Precision Medicine Introduction
11.19.4 Pacific Biosciences Revenue in Oncology Precision Medicine Business (2017-2022)
11.19.5 Pacific Biosciences Recent Developments
11.20 Quest Diagnostics
11.20.1 Quest Diagnostics Company Details
11.20.2 Quest Diagnostics Business Overview
11.20.3 Quest Diagnostics Oncology Precision Medicine Introduction
11.20.4 Quest Diagnostics Revenue in Oncology Precision Medicine Business (2017-2022)
11.20.5 Quest Diagnostics Recent Developments
11.21 Qiagen
11.21.1 Qiagen Company Details
11.21.2 Qiagen Business Overview
11.21.3 Qiagen Oncology Precision Medicine Introduction
11.21.4 Qiagen Revenue in Oncology Precision Medicine Business (2017-2022)
11.21.5 Qiagen Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
